Clinical Trials Sponsored by Beijing HuiNengAn Biotech Company

Total 30 results

Xuanwu Hospital, Beijing
Beijing Mario Biotech Company; Hebei Senlang BIotech Company; Beijing HuiNengAn...

Recruiting

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Glioma | Malignant Glioma of Brain | Recurrence Tumor

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)

Whooping Cough | Tetanus | Diphtheria

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)

Covid19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Completed

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (COVID-19)

COVID-19 | COVID-19 Pneumonia

United Arab Emirates
The Affiliated Hospital of the Chinese Academy...
Beijing Genova Biotech Company, Ltd.

Completed

Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Shulan (Hangzhou) Hospital

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and Above (COVID-19)

COVID-19

China
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Beijing...

Completed

Immunogenicity and Safety of Sabin-IPV Replacement Vaccination

Vaccination

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological... and other collaborators

Completed

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)

COVID-19

Jordan, Bahrain, Egypt, United Arab Emirates
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
Sinopharm Wuhan Plasma-derived Biotherapies Co....
China National Biotec Group Company Limited; Beijing Tiantan Biological Products...

Not yet recruiting

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

COVID-19

United Arab Emirates
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Zhejiang Provincial Center...

Not yet recruiting

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD

COVID-19 | COPD | Chronic Bronchitis

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

Varicella

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for...

Active, not recruiting

Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above (COVID-19)

COVID-19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Zhejiang Provincial Center...

Not yet recruiting

Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected

HIV Infections | COVID-19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Zhejiang Provincial Center...

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD

COVID-19 | COPD | Chronic Bronchitis

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Zhejiang Provincial Center...

Recruiting

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV Infected

HIV Infections | COVID-19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age

Varicella

China
China National Biotec Group Company Limited
The University of Hong Kong; Beijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological Products Co., Ltd

Active, not recruiting

Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above (COVID-19)

COVID-19

Hong Kong
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Coronavirus Infections | COVID-19

United Arab Emirates
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Recruiting

A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

COVID-19

United Arab Emirates
National Vaccine and Serum Institute, China
China National Biotec Group Company Limited; Lanzhou Institute of Biological... and other collaborators

Recruiting

Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Coronavirus Infections | COVID-19 Pneumonia

United Arab Emirates
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hubei Provincial Center for... and other collaborators

Unknown

Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA

Vaccination

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Guizhou Center for Disease... and other collaborators

Recruiting

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

COVID-19 | Rabies

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for... and other collaborators

Completed

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Hunan Provincial Center for... and other collaborators

Not yet recruiting

Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

COVID-19 Pneumonia

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological... and other collaborators

Unknown

Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP

Vaccination

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Sichuan Center for Disease... and other collaborators

Completed

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

Covid19 | Pneumonia, Pneumococcal | Influenza, Human

China
China National Biotec Group Company Limited
Xiangya Hospital of Central South University; Beijing Institute of Biological... and other collaborators

Recruiting

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

COVID-19 | Hemolysis

China
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaborators

Completed

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Vaccination

China
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaborators

Unknown

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Vaccine

China

Clinical Trials Sponsored by Beijing HuiNengAn Biotech Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations